Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GSC Pharma is a pharmaceutical company based in Hyderabad, India, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical pellets, and finished dosage forms. The company is particularly recognized for its expertise in pelletization technology, providing advanced drug delivery solutions such as sustained-release and enteric-coated pellets. Their core product portfolio focuses on therapeutic areas including gastroenterology, antifungal treatments, and cardiovascular health, featuring widely used generic compounds like Omeprazole and Itraconazole. GSC Pharma operates manufacturing facilities that adhere to international quality standards, serving as a key supplier and contract manufacturer for global markets. The company maintains a strong export presence, providing high-quality pharmaceutical intermediates to partners across Asia, Africa, and Latin America.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GSC Pharma.